Europe Bioinformatics Market is segmented By Products and Services (Knowledge Management Tools, Bioinformatics Services, and Bioinformatics Platforms) By Application (Genomics, Drug Design, Proteomics, Transcriptomics and Others), and by Country (UK, France, Spain, Germany, Italy, and Rest of Europe) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Europe Bioinformatics Market Overview
The Europe Bioinformatics Market is expected to grow at a CAGR of 14.3% during the forecast period 2023-2030.
Bioinformatics is a branch of science that integrates computer programming, big data, and Molecular Biology to help scientists comprehend and detect patterns in biological data. It is especially valuable in genome research and DNA sequencing since it helps scientists to arrange vast volumes of data.
There are several fields of Biology to specialize in, ranging from genetics to toxicology to mycology and radiobiology. Bioinformatics is one of the fascinating topics that allows you to find, assess, store, and retrieve biological information. As an interdisciplinary topic of research, it combines applications of Computer Science, Statistics, and Biology to create software applications for interpreting biological data such as DNA sequencing, protein analysis, evolutionary genetics, and so on.
Important bioinformatics choices on drug development will be made in the future by individuals who not only understand biology but can also utilize bioinformatics tools and the information they release to create hypotheses and find excellent targets.
Report Scope
|
Metrics |
Details |
|
CAGR |
14.3% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Products and Services and Application |
|
Countries Covered |
UK, France, Spain, Germany, Italy, and Rest of Europe |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Market Drivers
Growing Demand for Bioinformatics
Next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumours and specific receptors as genomics-focused pharmacology continues to play a greater role in the treatment of various chronic diseases, particularly cancer. Informatics is important in biological research because it involves biologists who study programming, computer programmers, mathematicians, or database administrators who understand the fundamentals of biology.
For example, NGS has been investigated for complete profiling of pharmacogenetics with relevance to drug pharmacokinetics and pharmacodynamics. According to early research published, this method might be a reliable and effective tool for detecting both common and unusual genetic variants in these genes.
Bioinformatics is the use of computational and analytical methods for the collection and interpretation of biological data.
By using genome-focused pharmacology to treat chronic illnesses, bioinformatics has the potential to change the face of cancer and advance the concept of precision medicine. As a result, the increased use of genome-focused pharmacology for chronic illness therapy drives the bioinformatics market.
Market Opportunities
Strategic Initiatives by Market Players Creates Significant Opportunities for the Market
Bioinformatics, a branch of life science concerned with genome understanding and planning, provides useful biological information. A genome is the complex organization of genetic sets found in a cell or a living entity as a whole. Personalized medicine is a multifaceted approach to dealing with individual health care needs. Bioinformatics techniques aided in the creation of patient-specific medications.
For example, Quest Diagnostics Incorporated invested in Structural Bioinformatics, A Leader in Computational Proteomics, and Structural Pharmacogenomics in December 2020. The investment resulted in the combined production of a series of database modules of innovative, structurally variant proteins, as well as the direct marketing of these goods to the pharmaceutical and biotechnology industries for use in the development of customized medicine.
As a result of the rising frequency of chronic illness and increased drug-resistance difficulties in conventional therapy, there is a greater need for improved bioinformatics in drug development. This is anticipated to be one of the primary factors driving market expansion over the projected period.
Europe Bioinformatics Industry Segmentation
The Europe bioinformatics market is segmented by products and services, and application.
Based on application, the genomics segment is expected to dominate the market over the forecast years. It is largely attributed to different technical improvements connected with handling a large number of genomic data, as well as the growing demand for pharmacogenomics in sequence screening and medication development.
Furthermore, expanding prospects and potential relevance of genomes in clinical research are driving demand for genomics applications and enhancing the growth of the Europe bioinformatics market.
Regional Insights
By country the Europe bioinformatics market is segmented into UK, France, Spain, Germany, Italy, and Rest of Europe.
The European market was the world's second-largest market in 2020. Factors such as growing protein and nucleic acid sequencing demand, higher research funding, and technical developments are projected to drive the growth of this market in the region.
The German bioinformatics market is predicted to hold the largest share of the European Bioinformatics market, as well as the bioinformatics markets in France and the United Kingdom, which are expected to grow at the fastest CAGR. Rising disposable income in the nations, as well as consumer adoption of new technologies, are expected to boost market demand. Furthermore, the increased adoption of sophisticated tools by end-users is likely to drive Bioinformatics growth throughout the projection period.
Market Leaders
Some of the key players contributing to the Europe Bioinformatics Market growth are Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Biomax Informatics Ag, DNAnexus, Inc., and Waters Corporation.
